Jiangyan Xu
Biographic Data
| ID | 7278850 |
|---|---|
| NAME | Jiangyan Xu |
| GIVEN NAMES | Jiangyan |
| FAMILY NAME | Xu |
| SIGNATURE | XU J |
| AFFILIATIONS | First Affiliated Hospital of Henan University |
| ORCID | 0000-0002-8723-1463 |
| VERIFIED | No |
| TOTAL WORKS | 4 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 4 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2014 |
| LATEST PUBLICATION YEAR | 2026 |
| H-INDEX | 0 |
Salvianolic acid C, a novel pyroptosis inhibitor, attenuates podocyte injury in diabetic kidney disease through regulating miRNA-21/A20 pathway
Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1
Zexie Tang targeting FKBP38/mTOR/SREBPs pathway improves hyperlipidemia
Interaction of body mass index and hemoglobin concentration on blood pressure among pregnant women in Guangxi, China
Our findings suggest that high BMI and high Hb concentrations may have a synergistic effect on blood pressure in late stage of pregnancy
No prominent works on this page.
Interaction of body mass index and hemoglobin concentration on blood pressure among pregnant women in Guangxi, China
Our findings suggest that high BMI and high Hb concentrations may have a synergistic effect on blood pressure in late stage of pregnancy
Zexie Tang targeting FKBP38/mTOR/SREBPs pathway improves hyperlipidemia
Yishen Tongluo formula alleviates diabetic kidney disease through regulating Sirt6/TGF-β1/Smad2/3 pathway and promoting degradation of TGF-β1
Salvianolic acid C, a novel pyroptosis inhibitor, attenuates podocyte injury in diabetic kidney disease through regulating miRNA-21/A20 pathway
Chronic Kidney Disease and Diabetes (2 works) · Diabetes mellitus (2 works) · Endocrinology (2 works) · Internal Medicine (2 works) · Kidney (2 works) · Kidney disease (2 works) · Medicine (2 works) · Pharmacology (2 works) · Signal transduction (2 works) · Apoptosis (1 works)